Neuraxis (NRXS) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Neuraxis insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $1.4M and 0 sold $0 of NRXS stock on the open market.
Get emailed when insiders cluster-buy stocks like NRXS
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NRXS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $12K | 3 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $32K | 3 | — | 0 |
| Q1 2026 | $383K | 2 | — | 0 |
| Q4 2025 | $1.0M | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Neuraxis, INC insiders reported open-market purchases totaling $1.4M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Brian Hannasch (10% Owner) has the highest Insider Score at 84.
NRXS stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 8SEC | Timothy Robert HenrichsCFO | Buy | 1,9379,530 held (+26%) | $4.84 | $9K | +43.2% | — |
| Oct 8SEC | Thomas Joeseph CarricoCro, Cco, Cpo | Buy | 328199,673 held (+0%) | $4.84 | $2K | +43.2% | — |
| Oct 8SEC | Brian Allen CarricoCEO | Buy | 268227,604 held (+0%) | $4.84 | $1K | +43.2% | — |
| Apr 3SEC | Brian Allen CarricoCEO | Buy | 8,060348,178 held (+2%) | $1.96 | $16K | +253.6% | — |
| Apr 3SEC | Timothy Robert HenrichsCFO | Buy | 7,593new position | $1.96 | $15K | +253.6% | — |
| Apr 3SEC | Thomas Joeseph CarricoCro, Cco, Cpo | Buy | 667331,903 held (+0%) | $1.96 | $1K | +253.6% | — |
| Feb 13SEC | Brian Hannasch10% Owner | Buy | 40,0001,211,522 held (+3%) | $4.92 | $197K | +40.9% | 84 |
| Feb 13SEC | Brian Hannasch10% Owner | Buy | 40,0001,171,522 held (+4%) | $4.65 | $186K | +49.0% | 84 |
| Dec 29SEC | Gil AharonDirector | Buy | 286,138new position | $3.52 | $1.0M | +96.9% | — |
Insiders at Neuraxis, INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Gil AharonDirector | $1.0M | — | Dec 29, 2025 | — |
| Brian Hannasch10% Owner | $383K | — | Feb 13, 2026 | 84 |
| Timothy Robert HenrichsCFO | $24K | — | Oct 8, 2026 | — |
| Brian Allen CarricoCEO | $17K | — | Oct 8, 2026 | — |
| Thomas Joeseph CarricoCro, Cco, Cpo | $3K | — | Oct 8, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
NRXS stock: common questions
Are Neuraxis, INC insiders buying NRXS stock?
In the past 12 months, 4 insiders reported open-market purchases of NRXS worth $1.4M. The latest was CFO Timothy Robert Henrichs bought $9K of NRXS at $4.84 — raises the stake by 26%.
Are Neuraxis, INC insiders selling NRXS stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NRXS's 52-week range?
Over the past year NRXS has traded between $2.31 and $8.81. It last closed at $6.93 on Oct 9, 2026.